Literature DB >> 10879733

Acute humoral xenograft rejection: destruction of the microvascular capillary endothelium in pig-to-nonhuman primate renal grafts.

A Shimizu1, S M Meehan, T Kozlowski, T Sablinski, F L Ierino, D K Cooper, D H Sachs, R B Colvin.   

Abstract

The major cause of xenograft loss beyond hyperacute rejection is a form of injury, traditionally termed delayed xenograft rejection (DXR), whose pathogenesis is unknown. Here we analyze the immunologic and morphologic features of DXR that develops in pig kidney xenografts transplanted into nonhuman primates. Kidneys from miniature swine were transplanted into cynomolgus monkeys (n = 14) or baboons (n = 11) that received regimens aimed to induce mixed chimerism and tolerance. No kidney was rejected hyperacutely. Morphologic and immunohistochemical studies were performed on serial biopsies, and an effort was made to quantify the pathologic features seen. The early phase of DXR (Days 0-12) was characterized by focal deposition of IgM, IgG, C3, and scanty neutrophil and macrophage infiltrates. The first abnormality recognized was glomerular and peritubular capillary endothelial cell death as defined by in situ DNA nick-end labeling (TUNEL). Damaged endothelial cells underwent apoptosis and, later, frank necrosis. The progressive phase developed around Day 6 and was characterized by progressive deposition of IgM, IgG, C3, and prominent infiltration of cytotoxic T cells and macrophages, with a small number of NK cells. Thrombotic microangiopathy developed in the glomeruli and peritubular capillaries with TUNEL+ endothelial cells, platelet aggregation, and destruction of the capillary network. Only rare damaged arterial endothelial cells and tubular epithelial cells were observed, with rare endothelialitis and tubulitis. In the advanced phase of DXR, interstitial hemorrhage and infarction occurred. During the development of DXR, the number of TUNEL+ cells increased, and this correlated with progressive deposition of antibody. The degree of platelet aggregation correlated with the number of TUNEL+ damaged endothelial cells. We conclude that peritubular and glomerular capillary endothelia are the primary targets of renal DXR rather than tubular epithelial cells or arterial endothelium and that the earliest detectable change is endothelial cell death. DXR was characterized by progressive destruction of the microvasculature (glomeruli and peritubular capillaries) and formation of fibrin-platelet thrombi. Both cytotoxic cells and antibodies potentially mediate the endothelial damage in DXR; however, in this model, DXR is largely humorally mediated and is better termed "acute humoral xenograft rejection."

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10879733     DOI: 10.1038/labinvest.3780086

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

Review 1.  Xenotransplantation: where are we today?

Authors:  M D Dooldeniya; A N Warrens
Journal:  J R Soc Med       Date:  2003-03       Impact factor: 5.344

2.  Pathologic characteristics of transplanted kidney xenografts.

Authors:  Akira Shimizu; Kazuhiko Yamada; Simon C Robson; David H Sachs; Robert B Colvin
Journal:  J Am Soc Nephrol       Date:  2011-11-23       Impact factor: 10.121

3.  Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.

Authors:  Y Masuda; A Shimizu; T Mori; T Ishiwata; H Kitamura; R Ohashi; M Ishizaki; G Asano; Y Sugisaki; N Yamanaka
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  Histopathology of pig kidney grafts with/without expression of the carbohydrate Neu5Gc in immunosuppressed baboons.

Authors:  Jeremy B Foote; Abhijit Jagdale; Takayuki Yamamoto; Hidetaka Hara; Mohamed H Bikhet; Henk-Jan Schuurman; Huy Q Nguyen; Mohamed Ezzelarab; David Ayares; Douglas J Anderson; Huma Fatima; Devin E Eckhoff; David K C Cooper; Hayato Iwase
Journal:  Xenotransplantation       Date:  2021-10-13       Impact factor: 3.788

5.  Anti-inflammatory and anticoagulant effects of transgenic expression of human thrombomodulin in mice.

Authors:  S Crikis; X M Zhang; S Dezfouli; K M Dwyer; L M Murray-Segal; E Salvaris; C Selan; S C Robson; H H Nandurkar; P J Cowan; A J F d'Apice
Journal:  Am J Transplant       Date:  2010-01-06       Impact factor: 8.086

6.  Rejection of cardiac xenografts transplanted from alpha1,3-galactosyltransferase gene-knockout (GalT-KO) pigs to baboons.

Authors:  Y Hisashi; K Yamada; K Kuwaki; Y-L Tseng; F J M F Dor; S L Houser; S C Robson; H-J Schuurman; D K C Cooper; D H Sachs; R B Colvin; A Shimizu
Journal:  Am J Transplant       Date:  2008-12       Impact factor: 8.086

7.  Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1,3-galactosyltransferase gene-knockout pigs in baboons.

Authors:  Akira Shimizu; Yosuke Hisashi; Kenji Kuwaki; Yau-Lin Tseng; Frank J M F Dor; Stuart L Houser; Simon C Robson; Henk-Jan Schuurman; David K C Cooper; David H Sachs; Kazuhiko Yamada; Robert B Colvin
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

8.  Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology.

Authors:  C K Burghuber; J Kwun; E J Page; M Manook; A C Gibby; F V Leopardi; M Song; A B Farris; J J Hong; F Villinger; A B Adams; N N Iwakoshi; S J Knechtle
Journal:  Am J Transplant       Date:  2016-03-25       Impact factor: 8.086

9.  Postmortem examination of the kidney in allogeneic hematopoietic stem cell transplantation recipients: possible involvement of graft-versus-host disease.

Authors:  Eiji Kusumi; Masahiro Kami; Shigeo Hara; Junichi Hoshino; Yutaka Yamaguchi; Naoko Murashige; Yukiko Kishi; Yugo Shibagaki; Taro Shibata; Tomoko Matsumura; Koichiro Yuji; Kazuhiro Masuoka; Atsushi Wake; Shigesaburo Miyakoshi; Shuichi Taniguchi
Journal:  Int J Hematol       Date:  2008-02-09       Impact factor: 2.490

Review 10.  B4GALNT2 and xenotransplantation: A newly appreciated xenogeneic antigen.

Authors:  Guerard Byrne; Saadullah Ahmad-Villiers; Zeji Du; Christopher McGregor
Journal:  Xenotransplantation       Date:  2018-03-31       Impact factor: 3.907

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.